Big Pharma Takes Another Hit Schering-Plough Corp., the maker of the Vytorin and Zetia cholesterol pills, said first-quarter profit fell 48 percent, less than analysts expected, on costs for acquiring Organon Biosciences NV. Profit excluding some items was 53 cents a share, … [Read more...] about Schering-Plough posts 48% drop
Birth Control
Thromboembolic Events with Ortho Evra Contraceptive Patch
New Data on Thromboembolic Events with Ortho Evra Contraceptive Patch The prescribing information for the Ortho Evra Contraceptive Transdermal Patch is being updated with results of a new study on the risk of venous thromboembolism. This study found that women aged 15-44 who … [Read more...] about Thromboembolic Events with Ortho Evra Contraceptive Patch
Johnson & Johnson’s Pre-Emption Defense Over Safety of Birth Control Patch
IN THE COURTS: New York Times Examines Johnson & Johnson's Pre-Emption Defense Over Safety of Birth Control Patch From DAILY WOMEN'S HEALTH POLICY REPORT, [April 8, 2008] The New York Times on Sunday examined Johnson & Johnson's use of the legal doctrine of preemption … [Read more...] about Johnson & Johnson’s Pre-Emption Defense Over Safety of Birth Control Patch
What Was Old Is New Again
Women Turning to Natural Methods of Birth Control Young women are turning to old ways to manage fertility cycles. Amanda Zamani of Asheville, N.C., never really liked hormonal birth control and its effects on her body. She had a hard time remembering to take a birth-control pill … [Read more...] about What Was Old Is New Again
Research and Markets: Contraception Market Report 2007
Research and Markets has announced the addition of Contraception Market Report 2007 to their offering. The UK market for contraceptives, as evaluated in this report, comprises four main sectors: hormone-based products; barrier products; intra-uterine device (IUD) products and … [Read more...] about Research and Markets: Contraception Market Report 2007